Published in J Mol Biol on September 10, 2004
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17
Biology of interleukin-22. Semin Immunopathol (2010) 2.92
Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem (2009) 1.73
Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure (2010) 1.63
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure (2008) 1.23
Structural and biophysical studies of the human IL-7/IL-7Ralpha complex. Structure (2009) 1.07
Cytokine-receptor interactions as drug targets. Curr Opin Chem Biol (2010) 0.98
Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res (2007) 0.86
A model of the ternary complex of interleukin-10 with its soluble receptors. BMC Struct Biol (2005) 0.86
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains. Biophys J (2007) 0.85
Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease. Front Cell Dev Biol (2016) 0.80
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.77
The crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22. Genes Immun (2014) 0.76
Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation. Front Immunol (2016) 0.75
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. Immunity (2017) 0.75
Interferons, interferon-like cytokines, and their receptors. Immunol Rev (2004) 6.21
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol (2004) 5.41
Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep (2002) 2.38
Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther (2006) 2.36
Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene (2004) 1.83
Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure (2010) 1.63
PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. J Biol Chem (2004) 1.63
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res (2006) 1.59
BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res (2006) 1.58
FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem Biophys Res Commun (2006) 1.54
Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene (2005) 1.49
Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis (2007) 1.40
Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci U S A (2002) 1.32
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem (2006) 1.31
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev (2003) 1.31
Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain. Structure (2005) 1.26
Binding and activity of all human alpha interferon subtypes. Cytokine (2011) 1.24
Chaperone Hsp27, a novel subunit of AUF1 protein complexes, functions in AU-rich element-mediated mRNA decay. Mol Cell Biol (2008) 1.23
Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure (2008) 1.23
Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Mol Cell Proteomics (2002) 1.18
Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther (2005) 1.10
Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS One (2012) 1.09
Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J Cell Physiol (2003) 1.09
Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. J Interferon Cytokine Res (2003) 1.05
AUF1 isoform-specific regulation of anti-inflammatory IL10 expression in monocytes. J Interferon Cytokine Res (2008) 1.04
Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines. Proc Natl Acad Sci U S A (2012) 1.03
Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev (2010) 1.03
Synergistic roles of eukaryotic translation elongation factors 1Bγ and 1A in stimulation of tombusvirus minus-strand synthesis. PLoS Pathog (2011) 1.03
Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Mol Cancer Ther (2010) 1.02
Chaperone Hsp27 modulates AUF1 proteolysis and AU-rich element-mediated mRNA degradation. Mol Cell Biol (2011) 1.01
RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes. Mol Cell Biol (2010) 1.00
Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration. J Immunol (2008) 0.99
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interferon Cytokine Res (2002) 0.98
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol (2014) 0.98
Cytokine-receptor interactions as drug targets. Curr Opin Chem Biol (2010) 0.98
Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains. Cell Res (2006) 0.98
Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3). Immunol Lett (2004) 0.98
A docking model based on mass spectrometric and biochemical data describes phage packaging motor incorporation. Mol Cell Proteomics (2010) 0.95
Structure of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr (2005) 0.94
An early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain core. J Virol (2004) 0.92
Evidence that eukaryotic translation elongation factor 1A (eEF1A) binds the Gcn2 protein C terminus and inhibits Gcn2 activity. J Biol Chem (2011) 0.91
Interactions among the components of the interleukin-10 receptor complex. Biochem Biophys Res Commun (2005) 0.91
Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc Natl Acad Sci U S A (2008) 0.90
Interferon-β signaling contributes to Ras transformation. PLoS One (2011) 0.89
Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway. Biochemistry (2005) 0.88
Spliceosome Sm proteins D1, D3, and B/B' are asymmetrically dimethylated at arginine residues in the nucleus. Biochem Biophys Res Commun (2004) 0.88
Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography. Structure (2002) 0.88
Historical developments in the research of interferon receptors. Cytokine Growth Factor Rev (2007) 0.87
Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques. PLoS One (2012) 0.84
Protein crystallization. Methods Mol Biol (2007) 0.84
Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity. Cytokine (2013) 0.83
Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus. PLoS One (2011) 0.83
The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding. J Virol (2006) 0.83
Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties. J Biol Chem (2012) 0.83
Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury. PLoS One (2010) 0.83
Vaccination against a virus-encoded cytokine significantly restricts viral challenge. J Virol (2013) 0.81
Interferon protects mice against inhalation anthrax. J Interferon Cytokine Res (2008) 0.81
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Res Ther (2011) 0.80
Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli. Protein Expr Purif (2006) 0.80
Analytical use of multi-protein Fluorescence Resonance Energy Transfer to demonstrate membrane-facilitated interactions within cytokine receptor complexes. Cytokine (2013) 0.79
Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase. Ann Clin Lab Sci (2008) 0.79
Modulation of the activation of Stat1 by the interferon-gamma receptor complex. Cell Res (2006) 0.79
Improving the spectral analysis of Fluorescence Resonance Energy Transfer in live cells: application to interferon receptors and Janus kinases. Cytokine (2013) 0.78
The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2. J Immunol (2006) 0.78
Site-specific 32P-labeling of cytokines, monoclonal antibodies, and other protein substrates for quantitative assays and therapeutic application. Biotechniques (2002) 0.77
Contamination with recombinant IFN accounts for the unexpected stimulatory properties of commonly used IFN-blocking antibodies. Eur J Immunol (2010) 0.77
Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers. Protein Sci (2013) 0.77
The old but new IgM Fc receptor (FcμR). Curr Top Microbiol Immunol (2014) 0.77
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.77
Crystallization and X-ray diffraction analysis of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr (2004) 0.76
Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes. Front Biosci (2006) 0.76
Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions. Bosn J Basic Med Sci (2016) 0.75
Purification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Short communication: adhesion pathways utilized by HIV-infected lymphocytes. AIDS Res Hum Retroviruses (2012) 0.75
A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction. Ann Clin Lab Sci (2003) 0.75
Crystallization of cytokine-receptor complexes. Methods Mol Biol (2004) 0.75
ELISA measurement of interferons. Biotechniques (2002) 0.75
The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein. Front Biosci (2007) 0.75
Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions. Bosn J Basic Med Sci (2016) 0.75
Design and construction of a phosphorylatable chimeric monoclonal antibody with a highly stable phosphate. Oncol Res (2004) 0.75